Viewing nowCombinationLozataplus Tablets
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.

MFDS item code 201708478 · Approved 2017.12.21 · Insurance code 647204820
Treatment of hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with hypertension whose blood pressure is not adequately controlled with monotherapy.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Replacement therapy: A combination regimen of individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who develop hypokalemia despite blood pressure control at this dose: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. Continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose if creatinine clearance is 30 mL/min or higher. Administration is not recommended in patients with more severe renal impairment, because loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration is not recommended in patients with hepatic impairment requiring dose adjustment, because the initial dose of losartan potassium of 25 mg for these patients cannot be administered using this medicine.
○ Children (under 18 years) There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with certain diseases or who are hypersensitive to the drug, and it is contraindicated in patients with severely impaired kidney or liver function, pregnant women, and patients with certain genetic diseases. Patients with hypotension, kidney disease, liver disease, hyperuricemia, cerebrovascular disorders, etc., should use this medication with caution, especially elderly patients or those with diabetes should be careful. This medication has the effect of lowering blood pressure, so dizziness or drowsiness may occur during treatment, and care should be taken when driving or operating machinery. The component Hydrochlorothiazide may cause electrolyte imbalance in the body, so regular blood tests to check electrolyte levels such as sodium and potassium should be performed, and care should be taken to avoid dehydration. This medication can interact with other drugs, so be sure to consult a doctor when taken with potassium-sparing diuretics, potassium supplements, certain analgesics, or antihyperglycemic agents. If new skin lesions appear or existing skin conditions worsen during treatment, consult a healthcare professional immediately, and avoid sun exposure and use UV protection. In case of overdose, symptoms such as hypotension or cardiac arrhythmia may occur, so strictly adhere to the prescribed dosage, and notify a healthcare professional immediately if any abnormal symptoms occur. This medication has not established safety and efficacy in children and adolescents, so it should not be used in these populations. Breastfeeding women should consider discontinuing breastfeeding or the medication since this medication may be excreted in breast milk, and women planning pregnancy or who might be pregnant should consult a doctor before taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that can block light, and it is recommended to store it at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the medication's efficacy and prevent degradation.
Pale yellow oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.